Cargando…
IFITM3 promotes hepatocellular carcinoma invasion and metastasis by regulating MMP9 through p38/MAPK signaling
Interferon‐induced transmembrane protein 3 (IFITM3) has been shown to be overexpressed in multiple cancers. However, the role of IFITM3 in metastasis of hepatocellular carcinoma (HCC) is still poorly understood. In this study, we showed that IFITM3 was frequently overexpressed in HCC tissues compare...
Autores principales: | Min, Jiaqi, Feng, Qian, Liao, Wenjun, Liang, Yiming, Gong, Chengwu, Li, Enliang, He, Wenfeng, Yuan, Rongfa, Wu, Linquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070650/ https://www.ncbi.nlm.nih.gov/pubmed/30087833 http://dx.doi.org/10.1002/2211-5463.12479 |
Ejemplares similares
-
miR-29a suppresses the growth and metastasis of hepatocellular carcinoma through IFITM3
por: Liang, Yiming, et al.
Publicado: (2018) -
TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a
por: Liu, Weiwei, et al.
Publicado: (2021) -
Rare anatomic variation of the right hepatic artery and accessory right hepatic artery supplying hepatocellular carcinoma: A case report and literature review
por: Liang, Yiming, et al.
Publicado: (2017) -
MicroRNA‑181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG
por: Ai, Jiyuan, et al.
Publicado: (2019) -
The diagnostic value of assays for circulating tumor cells in hepatocellular carcinoma: A meta-analysis
por: Sun, Chi, et al.
Publicado: (2017)